These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 36749087)
1. Stromal Interaction Molecule 1 (STIM1) is a Potential Prognostic Biomarker and Correlates with Immune Infiltrates in Solid Tumors. Zhang Z; Wang Z; Liu Y; Zhao L; Fu W J Environ Pathol Toxicol Oncol; 2023; 42(2):11-30. PubMed ID: 36749087 [TBL] [Abstract][Full Text] [Related]
2. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures. Zhang X; Wang Y; A G; Qu C; Chen J Front Immunol; 2021; 12():721030. PubMed ID: 34531868 [TBL] [Abstract][Full Text] [Related]
3. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers. Wang N; Zhu L; Wang L; Shen Z; Huang X Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736 [TBL] [Abstract][Full Text] [Related]
4. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas. Zhao S; Li Y; Xu J; Shen L Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705 [TBL] [Abstract][Full Text] [Related]
5. Identifies microtubule-binding protein Wang W; Zhang J; Wang Y; Xu Y; Zhang S Comput Struct Biotechnol J; 2022; 20():3322-3335. PubMed ID: 35832625 [TBL] [Abstract][Full Text] [Related]
6. Distinct Roles of Adenosine Deaminase Isoenzymes ADA1 and ADA2: A Pan-Cancer Analysis. Gao ZW; Yang L; Liu C; Wang X; Guo WT; Zhang HZ; Dong K Front Immunol; 2022; 13():903461. PubMed ID: 35663977 [TBL] [Abstract][Full Text] [Related]
7. Pan-cancer analysis predicts CANT1 as a potential prognostic, immunologic biomarker. Yang W; Liu Z; Liu T Cell Signal; 2024 May; 117():111107. PubMed ID: 38369265 [TBL] [Abstract][Full Text] [Related]
8. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma. Sun K; Chen RX; Li JZ; Luo ZX Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179 [TBL] [Abstract][Full Text] [Related]
9. Comprehensive Pan-Cancer Analysis of KIF18A as a Marker for Prognosis and Immunity. Liu T; Yang K; Chen J; Qi L; Zhou X; Wang P Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830695 [TBL] [Abstract][Full Text] [Related]
10. Comprehensive bioinformatic analysis of mind bomb 1 gene in stomach adenocarcinoma. Wang D; Wang QH; Luo T; Jia W; Wang J World J Gastrointest Oncol; 2023 Jul; 15(7):1295-1310. PubMed ID: 37546549 [TBL] [Abstract][Full Text] [Related]
11. Cartilage oligomeric matrix protein acts as a molecular biomarker in multiple cancer types. Guo B; Wang Y; Liu W; Zhang S Clin Transl Oncol; 2023 Feb; 25(2):535-554. PubMed ID: 36255654 [TBL] [Abstract][Full Text] [Related]
12. Pan-cancer analysis of prognostic and immunological role of DTYMK in human tumors. Zhao H; Xie R; Zhang C; Lu G; Kong H Front Genet; 2022; 13():989460. PubMed ID: 36159971 [No Abstract] [Full Text] [Related]
13. SHMT2 is Associated with Tumor Purity, CD8+ T Immune Cells Infiltration, and a Novel Therapeutic Target in Four Different Human Cancers. Usman M; Hameed Y; Ahmad M; Iqbal MJ; Maryam A; Mazhar A; Naz S; Tanveer R; Saeed H; Bint-E-Fatima ; Ashraf A; Hadi A; Hameed Z; Tariq E; Aslam AS Curr Mol Med; 2023; 23(2):161-176. PubMed ID: 35023455 [TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis of tumor necrosis factor-α-inducible protein 8-like 2 (TIPE2): A potential novel pan-cancer immune checkpoint. Bai KH; Zhang YY; Li XP; Tian XP; Pan MM; Wang DW; Dai YJ Comput Struct Biotechnol J; 2022; 20():5226-5234. PubMed ID: 36187930 [TBL] [Abstract][Full Text] [Related]
15. Roles of cuproptosis-related gene DLAT in various cancers: a bioinformatic analysis and preliminary verification on pro-survival autophagy. Yang Q; Zeng S; Liu W PeerJ; 2023; 11():e15019. PubMed ID: 36949759 [TBL] [Abstract][Full Text] [Related]
16. The molecular feature of macrophages in tumor immune microenvironment of glioma patients. Zhang H; Luo YB; Wu W; Zhang L; Wang Z; Dai Z; Feng S; Cao H; Cheng Q; Liu Z Comput Struct Biotechnol J; 2021; 19():4603-4618. PubMed ID: 34471502 [TBL] [Abstract][Full Text] [Related]
17. A pan-cancer analysis of the prognostic implication and oncogenic role of tubulin epsilon and delta complex 2 (TEDC2) in human tumors. Liu Y; Zhu J; Shen J; Lu Y; Pan K; Tong C; Wang Y Front Immunol; 2023; 14():1272108. PubMed ID: 38239349 [TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of zinc and ring finger 3 in prognostic value and pan-cancer immunity. Liu M; Zhao H; Peng S; Wu Y; Liu Y; Sun W; Zen K; Sun X FASEB J; 2024 Mar; 38(5):e23523. PubMed ID: 38457275 [TBL] [Abstract][Full Text] [Related]
19. Comprehensive Analysis Reveals Deoxyribonuclease 1 as a Potential Prognostic and Diagnostic Biomarker in Human Cancers. Eletr LF; Ibnouf SH; Salih TA; Ibrahim HI; Mustafa MI; Alhashmi NA; Alfaki M Cureus; 2024 Mar; 16(3):e56171. PubMed ID: 38618458 [TBL] [Abstract][Full Text] [Related]
20. Non-SMC condensin I complex subunit D2 (NCAPD2) reveals its prognostic and immunologic features in human cancers. Dong X; Liu T; Li Z; Zhai Y Aging (Albany NY); 2023 Jul; 15(14):7237-7257. PubMed ID: 37498296 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]